Kamar yadda aka tattauna a cikin muƙalar gabatarwa a cikin wannan jerin, ƙa'idar da ta dace da alluran rigakafi - wacce ta shafi gwaje-gwajen asibiti, lasisi, tallatawa, da jadawalin allurar rigakafi - galibi wani abu ne na kimiyya da aka gina bisa tushen ƙarya mai rauni. A cikin wannan jerin, mun bincika kowanne daga cikin Manyan Ƙarya guda biyar da ke ƙarfafa ilimin allurar rigakafi, tare da "Ambato Mai Girma" guda biyu.
Manyan Karya Biyar na Ilimin Alurar riga kafi
Babban Ƙarya #1: Daidaita Samar da Magungunan Jiki da Kariya ga Cututtuka
Babban Ƙarya #2: Amfani da Placebos na Karya
Babban Ƙarya #3: Nacewa Kariyata Ya dogara ne akan Allurar Rigakafinka
Babban Ƙarya #4: Bayyana Allurai da yawa a lokaci guda don su zama lafiya.
Babban Ƙarya #5: Bayyana Allurar Rigakafi a Matsayin "Lafiya da Inganci" A Matsayin Aji
Muhimmin ambato na 1: Bayyana magungunan mRNA na kwayoyin halitta a matsayin allurar rigakafi
Ambato Mai Girma Na Biyu: Ba da damar Kamfanonin Laifuka su Gudanar da Nazari na Asibiti nasu
Babban Ƙarya #1: Daidaita Samar da Magungunan Jiki da Kariya ga Cututtuka
Daidaita samar da kwayoyin cuta da garkuwar jiki ga cututtuka yana ɗaya daga cikin manyan ƙaryar da ake yi wa allurar rigakafi. Masu kera allurar rigakafi suna tallata wannan daidaiton ƙarya a gwaje-gwajen asibiti da kuma tallata kayayyakinsu, ga masu kula da lafiya da kuma ga jama'a.
Misali, bin diddigin jama'ar Shugaba Trump bayani a ranar 1 ga Satumba, 2025 cewa dole ne masu kera sabbin allurar Covid-19 su bayyana bayanansu game da ingancin allurar su ga jama'a, Pfizer ya fitar da wata sanarwa a ranar 8 ga Satumba. Babban ikirarin Pfizer game da sabon allurar Covid-19 dinsa ya karanta:
- Gwajin asibiti na mataki na 3 na manya 'yan shekara 65+ da 18-64 waɗanda ke da aƙalla yanayin haɗari ɗaya ya nuna aƙalla ƙaruwa sau 4 a cikin adadin ƙwayoyin rigakafi na LP.8.1 bayan sun sami allurar rigakafin COVID-19 ta LP.8.1 da aka daidaita ta 2025-2026.
Wannan na iya yin kama da abin mamaki. Bayan haka, shine taken Pfizer da kansa ya zaɓa. An tallata shi a matsayin tabbatar da cewa hoton "yana aiki," kuma an sanya shi a saman layin sanarwar manema labaran su.
Menene shi zahiri ya ce alluran sun sa waɗanda aka yi wa allurar suka samar da wani takamaiman maganin rigakafi sau 4 fiye da da. Shi ke nan.
Ba ya ƙarfafa bayanai kafin a fara amfani da su a asibiti, kamar yadda Pfizer ya yi iƙirari, "yana ƙarfafa bayanan da aka riga aka yi amfani da su a asibiti waɗanda suka goyi bayan amincewa da Hukumar Abinci da Magunguna ta Amurka (FDA) ta kwanan nan na allurar rigakafin Covid-19 da aka daidaita ta LP.8.1, wanda ya nuna ingantattun martanin rigakafi kan ƙananan nau'ikan SARS-CoV-2 da ke yaɗuwa."
Kawai dai hayaniya ce.
Kamar wani wakilin wasanni ne mai kwadayi da kishi wanda ya ayyana cewa matashin ɗan wasansa mai shekaru 18 a matsayin ɗan wasan gaba na Major League All-Star, kawai saboda matashin ɗan wasansa zai iya yin gudu mil 98 a kowace awa.
Yaron na iya samun hannu mai ƙarfi. Amma idan ya kasa jefa yajin aiki, ba shi da amfani.
Samar da ƙwayoyin rigakafi, ko da ƙarfi ne ko a'a, ba garantin garkuwar jiki ta gaske ba ce. A'a ko kaɗan. Iƙirarin cewa idan allurar rigakafi ta haifar da ƙarfin garkuwar jiki, saboda haka zai kare ka daga kamuwa, yaɗuwa, ko rashin lafiya daga wata cuta, ra'ayi ne mara kyau da aka dogara da shi bisa hujjar ƙarya.
Akwai manyan dalilai guda biyu da yasa daidaiton samar da antibody da garkuwar jiki daga cututtuka karya ne:
- Aikin garkuwar jiki ya ƙunshi fiye da martanin antibody.
- Maganin rigakafi da aka auna a gwaje-gwajen asibiti na iya zama ba shi da mahimmanci da/ko kuma ya tsufa ga cutar da ake magana a kai.
Aikin Tsarin Garkuwar Jiki Ya Shafi Fiye da Amsar Antibody
Hujja ta farko ita ce samar da antibody shine jimlar aikin tsarin garkuwar jiki. Sakamakon - wanda kuma ƙarya ne - shine idan za ku iya nuna samar da antibody daga allurar rigakafi, kun nuna cewa yana ba da kariya daga cututtuka. Wannan kuskuren siffanta tsarin garkuwar jiki ne da gangan.
An yi amfani da wannan hanyar ƙarya ta auna abin da ake kira "immunogenicity" a duk faɗin masana'antar allurar rigakafi saboda tana samar da abin da za a iya faɗi kuma za a iya aunawa. wanda zai maye gurbinsa don ingantaccen aikin garkuwar jiki. Duk da haka, wannan madadin bai isa ba kuma yana ɓatarwa.
Tsarin garkuwar jikin ɗan adam yana da matuƙar rikitarwa, fiye da fahimtar ɗan adam gaba ɗaya, balle irin su Anthony Fauci, Albert Bourla, ko duk wani mai himma wajen allurar rigakafi da kuke son ambata. Kwayoyin rigakafi suna ɗaya daga cikin abubuwan da ke haifar da martanin garkuwar jiki ga kamuwa da cuta. Abu mai mahimmanci, amma ɗaya ce kawai.
Littattafan karatu galibi suna bayyana manyan rassan garkuwar jiki guda biyu: reshen da ke mai da hankali kan garkuwar jiki ta "murmushi", da kuma reshen da ke mai da hankali kan garkuwar jiki ta "cellular" (ta hanyar ƙwayoyin halitta). Sau da yawa ana cewa garkuwar jiki ta "humoral" tana mai da hankali kan cututtuka masu yaduwa, yayin da garkuwar jiki ta hanyar ƙwayoyin halitta ke mai da hankali kan kawar da cutar kansa.
Gaskiyar magana ita ce, waɗannan rassan guda biyu suna da alaƙa ta kut-da-kut ta hanyoyi masu rikitarwa, kuma wannan ƙwayar halitta (ko kuma idan kuna so, ba maganin rigakafi ba garkuwar jiki (intermediate) kuma muhimmin bangare ne na martanin cututtukan da ke yaɗuwa. Ta hanyar garkuwar jiki ne tsarin garkuwar jiki ke gane ƙwayoyin da ke kamuwa da ƙwayoyin cuta a cikin jiki kuma yana lalata su. Musamman tare da cututtukan ƙwayoyin cuta, lalata ƙwayoyin da suka kamu da cutar - waɗanda ke aiki a matsayin masana'antun ƙwayoyin cuta - babban abu ne ga rigakafi daga cutar.
Auna kwayoyin rigakafi guda ɗaya ko biyu a cikin 'yan makonni ko watanni a lokacin gwajin asibiti na allurar rigakafi ba ta nuna komai game da ingancin cikakken martanin garkuwar jiki da allurar da ake magana a kai za ta iya samarwa ba.
Ka tuna cewa, sabanin da maimaita da'awar na Pfizer, Fauci, Rochelle Walensky, kafofin watsa labarai na gado, da Joe "hunturu na rashin lafiya mai tsanani da mutuwa"Biden da kansa, allurar rigakafin cutar Pfizer Covid ta asali ba ta hana waɗanda aka yi wa allurar rigakafin kamuwa da ita ko yaɗa ta ba. Waɗannan allurar rigakafin ba su hana waɗanda aka yi wa allurar rigakafin kamuwa da cutar ba. yi suna samar da martani mai ƙarfi na antibody, amma suna ya yi ba hana mu yin rashin lafiya. Ko kusa ma ba mu yi ba.
(Abin sha'awa, a cikin kwanan nan Nazarin mataki na 3 Don allurar rigakafin mura da aka yi amfani da ita ta mRNA, Pfizer ya yi ƙaramin lanƙwasa ga garkuwar jiki ta ƙwayoyin halitta. Duk da haka, madadin da suka zaɓa su auna a cikin ƙaramin rukuni na marasa lafiya, wato adadin Interferon-gamma da ƙwayoyin T ke samarwa, an sauƙaƙa shi sosai kuma yana ɓatarwa - kamar ma'aunin ƙwayoyin cuta na rigakafi.)
Kwayoyin rigakafi da aka auna na iya zama marasa amfani da/ko kuma ba su da amfani ga ainihin cutar
Ka'ida ta biyu da ke tattare da daidaita samar da kwayoyin cuta da garkuwar jiki daga cututtuka ita ce ɗauka cewa maganin rigakafi da ake aunawa don nuna "immunogenicity" shine daidai don yaƙar cutar ta gaske. Ba kome ko nawa aka samar da maganin rigakafi idan maganin rigakafi ne mara kyau. (Kuma, idan mai jefa kwallo bai iya yin bugun ba, ba kome yadda zai iya yin ƙarfin hali ba.)
Kamar yadda muka gani, ƙwayoyin rigakafi kaɗai ba su isa su samar da kariya daga cututtuka ba. Amma ko da sun kasance, ƙwayoyin rigakafi ko ƙwayoyin rigakafi da wannan allurar rigakafin ke motsa samarwa a jikinka dole ne su yi daidai da ɓangaren da aka yi niyya na ƙwayar cuta - antigen - don samun sakamako mai kyau.
Wannan ba ya faruwa akai-akai saboda aƙalla dalilai biyu: saboda hanyoyin samar da allurar rigakafi ba su da inganci, kuma saboda antigens ɗin da ke cikin ƙwayoyin cuta suna ci gaba da canzawa.
Wannan babbar matsala gaskiya ce musamman - kuma mai sauƙin fahimta - idan aka yi la'akari da ƙwayoyin cuta na numfashi. Me yasa muke "buƙatar" sabon allurar mura kowace shekara? Me yasa a duniya aka "yi wa" allurar riga-kafi har zuwa bakwai ko takwas na Covid-19 cikin ƙasa da shekaru biyar?
Idan kwayar cuta ta sauya da sauri yayin da ake ci gaba da samar da allurar rigakafin da aka yi niyya a kanta, ƙwayoyin rigakafi da allurar rigakafi ke haifarwa, waɗanda aka tsara su don "tsohon" sigar kwayar cutar, ba za su gane sabon sigar antigen da aka canza ba wanda ake tsammanin za su haɗa da shi. A wata ma'anar, ba za su "manne" ba, kuma ba za su iya yin aikin da aka nufa ba.
Ƙananan ƙwayoyin cuta masu sauƙi na numfashi waɗanda ke ɗauke da RNA, kamar wanda ke haifar da Covid, mura, da mura mafi yawan gaske, suna canzawa cikin sauri da kuma koyaushe. Idan muka ji labarin sabon "nau'in" Covid, wannan yana nufin sabon samfurin wannan tsarin juyin halitta mai ci gaba.
Idan ya zo ga sauƙi, ƙwayoyin cuta masu saurin canzawa kamar SARS-CoV-2 ko mura, masu haɓaka allurar rigakafi kamar mai son zama fashionista ne wanda kawai ke siyayya a Basement na Filene. Ana kama su har abada a cikin neman banza don ci gaba da zamani, kodayake kawai suna da damar yin amfani da ƙirar kakar da ta gabata.
Duk da haka, idan masana'antun kamar Pfizer za su iya tallata kayayyakinsu yadda ya kamata, wannan lahani mai hatsari zai zama abin mamaki, ba kwaro ba. Idan har Pfizer zai iya sa mutane su gamsu cewa suna buƙatar ƙarin ƙarfi akai-akai, alluran rigakafi na yanayi suna wakiltar tsarin kasuwanci mara misaltuwa - lafiyar jama'a ta hanyar biyan kuɗi.
Masu Kula da Lafiya da Marasa Lafiya Ku Yi Hankali
Mayar da hankali kan matakan lafiya na bogi maimakon fa'idar asibiti mai ma'ana shine ginshiƙin tsarin Big Pharma na samun lasisin magunguna da kuma sayar da su ga jama'a. Tare da alluran rigakafi, ya fi sauƙi a nuna kasancewar wani alamar inganci kamar "samar da maganin rigakafi" fiye da nuna cewa allurar za ta hana ka yin rashin lafiya ko kuma ta ceci rayuwarka.
Samar da maganin rigakafi ba kariya ce ga cututtuka ba. Yaɗa wannan daidaiton ƙarya yana wakiltar Babban Ƙarya na farko na allurar rigakafi. Ganin dogon tarihinta na amfani da shi ba bisa ƙa'ida ba a cikin masana'antar, ya kamata masu kula da lafiya da marasa lafiya su ƙi shi a matsayin shaidar gaskiya ta ingancin allurar rigakafi a nan gaba.
-
CJ Baker, MD, Babban Malami na Brownstone, likita ne na cikin gida wanda ke da shekaru huɗu a fannin aikin likitanci. Ya yi naɗe-naɗen aikin likitanci da dama, kuma aikinsa ya bayyana a cikin mujallu da yawa, ciki har da Journal of the American Medical Association da New England Journal of Medicine. Daga 2012 zuwa 2018 ya kasance Farfesa na Asibiti na Humanities and Bioethics a Jami'ar Rochester.
Duba dukkan posts
